NCT00403754 - Dose Ranging Study for Indacaterol in Japanese Asthma Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Asthma

Interventions

DRUG

Indacaterol

In the morning, powder filled capsules inhaled using a single dose dry powder inhaler (SDDPI).

DRUG

Placebo

Placebo to indacaterol was provided in powder filled capsules with a single dose dry powder inhaler (SDDPI).

DRUG

Salmeterol

Salmeterol 100 μg total dose taken on Day 1. 50 μg in the morning and 50 μg twelve hours post initial dose inhaled via Diskus®, an inhalation device for Salmeterol.

Trial Locations (8)

Unknown

Novartis Investigative Site, Kasukabe

Novartis Investigator Site, Kishiwada

Novartis Investigative Site, Shimotsuga

Novartis Investigator Site, Suita

Novartis Investigative Site, Tokyo

Novartis, Tokyo

Novartis Investigator Site, Wakayama

Novartis Investigator Site, Yokohama